Reduced Liver RFP Fluorescence in LiPan Embryos and Fry
Animal study · LiPan embryos/fry [1]
The maximal reduction of RFP fluorescence observed: 41.1% by 1 mg/L phenylbutazone.
| Endpoint | Reported result | Reference |
|---|---|---|
| liver RFP intensity | liver RFP intensity 1 mg/L phenylbutazone: 41.1% reduction of RFP fluorescence | [1] |
Conditions shared by the study groups
- Route
- carried out in 6-well plates
- Treatment course
- from 3 hpf to 120 hpf
| Group / dose | Comparator | Observed result | Reference |
|---|---|---|---|
| Phenylbutazone 0.1–1 mg/L | respective controls | Maximal reduction of RFP fluorescence: 41.1% by 1 mg/L phenylbutazone. | [1] |
- Phenylbutazone 0.1–1 mg/L
- Model: LiPan embryos/fry
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Phenylbutazone
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Chemical Exposure to Zebrafish Fry (S6); Materials and Methods > Imaging and Data Analysis (S26); Results > Reduction of Liver Red Fluorescence and Size in LiPan Transgenic Fry by Hepatotoxins (S40, S41, S42)
liver RFP intensity: liver RFP intensity; comparator: respective controls — Results > Reduction of Liver Red Fluorescence and Size in LiPan Transgenic Fry by Hepatotoxins (S41, S42)
Phenylbutazone 0.1–1 mg/L · Materials and Methods > Chemical Exposure to Zebrafish Fry (S6); Results > Reduction of Liver Red Fluorescence and Size in LiPan Transgenic Fry by Hepatotoxins (S40, S42)